March 7, 2024
Criteria to Participate in the Emerging Technology Program To qualify for participation in the Emerging Technology Program, technologies need to: Have the potential to improve product […]
March 7, 2024
A Danish study showing that about half of patients with newly diagnosed inflammatory bowel disease (IBD) had findings consistent with spondyloarthritis (SpA) was highlighted as one […]
March 7, 2024
Benefits to participating in the Emerging Technology Program. Participants in the program can expect: Pre-submission face-to-face interactions with ETT members and review staff to answer technical […]
March 7, 2024
The Emerging Technology Program serves as an entry point for new technologies that will potentially be included in a regulatory filing for a specific drug product. […]
March 7, 2024
FDA recognizes that adopting innovative approaches to manufacturing may present both technical and regulatory challenges. Pharmaceutical companies may have concerns that developing such technologies could result […]
March 7, 2024
The risk of developing a new autoimmune inflammatory rheumatic disease (AIRD) is greater following a COVID-19 infection than after an influenza infection or in the general […]
March 7, 2024
(Reuters) – GSK said on Thursday a study showed its experimental drug Blenrep helped extend survival in patients with a type of blood cancer without symptoms […]
March 7, 2024
(Reuters) -Boehringer Ingelheim will cap out-of-pocket costs for the company’s inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, […]
March 7, 2024
LONDON (Reuters) – Sexually transmitted infections surged across Europe in 2022, with reported cases of gonorrhoea jumping by nearly a half, the European Centre for Disease […]